Disease-modifying anti-rheumatic drugs

DRUG2 trials

Sponsors

Hoffmann-La Roche, German University in Cairo

Conditions

Rheumatoid ArthritisRheumatoid Arthritis (RA)

Phase 2

L-carnitine Supplementation in Rheumatoid Arthritis Patients

RecruitingNCT06753565

German University in CairoRheumatoid Arthritis (RA)

Start: 2024-12-31End: 2025-06-30Target: 60Updated: 2025-01-07

Phase 3

An Extension Study of Tocilizumab (Myeloma Receptor Antibody [MRA]) in Patients Completing Treatment in Tocilizumab Core Studies

CompletedNCT00720798

Hoffmann-La RocheRheumatoid Arthritis

Start: 2005-09-30End: 2013-04-30Updated: 2014-09-30

Related Papers

Five-year Efficacy and Safety of Tocilizumab Monotherapy in Patients with Rheumatoid Arthritis Who Were Methotrexate- and Biologic-naive or Free of Methotrexate for 6 Months: the AMBITION Study.

2016-12-0126 citations